The following is a summary of “Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the ...

In the course of the ALS development program, however, dexpramipexole was observed to produce a significant and targeted depletion of eosinophils in the blood of ALS patients 4. Eosinophils are ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

People who have asthma are often treated with Benralizumab - a monoclonal antibody that targets specific white blood cells, called eosinophils, aimed at reducing lung inflammation. It is currently ...